Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Jefferies Downgrades Applied Molecular to Hold

Jefferies Downgrades Applied Molecular to Hold

Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.

July 7, 2022

1 minute read

Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.

Goldman Sachs Downgrades Harmony Biosciences to Neutral, Announces $55 Price Target

July 13, 5:51 AM

Goldman Sachs analyst Corinne Jenkins downgrades Harmony Biosciences (NASDAQ:HRMY) from Buy to Neutral and announces $55 price target.

March 10, 9:43 AM

Morgan Stanley analyst Josh Baer maintains Asana (NYSE:ASAN) with a Equal-Weight and raises the price target from $19 to $22.

December 8, 10:07 AM

Piper Sandler analyst Peter Keith maintains Ollie's Bargain Outlet (NASDAQ:OLLI) with a Overweight and lowers the price target from $75 to $60.

December 13, 11:21 AM

-Russian State Media